Income Statement Syensqo SA/NV

Stocks

SYENS

BE0974464977

Diversified Chemicals

Market Closed - Euronext Bruxelles Other stock markets 09:25:00 11/06/2026 pm IST			After hours 10:06:32 pm
65.00 ^EUR	+0.46%		65.05	+0.08%

08/06	Goldman Sachs Downgrades Syensqo to Sell, Cuts PT	MT
26/05	KBC Securities Raises Syensqo PT, Keeps at Accumulate	MT

ac1c8d6b068fee17522.sqmJ7jL4YIWIHqfsHNKdg2N-mE9X0eQSDYRxS9cpqVE.4sD4t0GZU9TQXZ-vS5OtxBAS3nYf4ql4P7IpIpt4-Cbq_PnWbc0KtcNJ6g

Published financial data: SYENSQO SA/NV

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	603.2Cr	812.3Cr	706.5Cr	684.6Cr	596.9Cr
Total Revenues	603.2Cr	812.3Cr	706.5Cr	684.6Cr	596.9Cr
Cost of Goods Sold, Total	414.8Cr	551.9Cr	469Cr	462.7Cr	412.3Cr
Gross Profit	188.4Cr	260.4Cr	237.5Cr	221.9Cr	184.6Cr
Selling General & Admin Expenses, Total	70Cr	84Cr	82Cr	100.5Cr	88Cr
R&D Expenses	29Cr	31Cr	34Cr	34Cr	30Cr
Other Operating Expenses	16Cr	14Cr	14Cr	16Cr	17Cr
Other Operating Expenses, Total	114.7Cr	130Cr	129.1Cr	150.4Cr	135Cr
Operating Income	74Cr	130.4Cr	108.4Cr	72Cr	50Cr
Interest Expense, Total	-11Cr	-13Cr	-20Cr	-12Cr	-13Cr
Interest And Investment Income	80L	3.4Cr	8.1Cr	2.2Cr	2.3Cr
Net Interest Expenses	-9.9Cr	-9.8Cr	-12Cr	-9.8Cr	-11Cr
Income (Loss) On Equity Invest.	1.3Cr	1.6Cr	2.5Cr	2.1Cr	1.9Cr
Currency Exchange Gains (Loss)	60L	-1Cr	-1.3Cr	-40L	-40L
Other Non Operating Income (Expenses)	-6.6Cr	-14Cr	-33Cr	-60L	-3.3Cr
EBT, Excl. Unusual Items	59Cr	107.2Cr	64Cr	63Cr	37Cr
Restructuring Charges	-9.2Cr	-2.6Cr	-6.2Cr	-9.4Cr	-9.5Cr
Merger & Related Restructuring Charges	-90L	10L	-21Cr	-8.5Cr	-19Cr
Impairment of Goodwill	-	-	-5.9Cr	-20L	-
Gain (Loss) On Sale Of Investments	60L	-1.3Cr	1Cr	-70L	-1.2Cr
Gain (Loss) On Sale Of Assets	30L	20L	-	10L	-
Asset Writedown	-	-	-6Cr	-6.2Cr	-7Cr
Insurance Settlements	-	-	3.2Cr	-	-
Legal Settlements	-2.4Cr	-7Cr	9.2Cr	-2.7Cr	3.4Cr
EBT, Incl. Unusual Items	48Cr	97Cr	39Cr	35Cr	4.2Cr
Income Tax Expense	2.2Cr	20L	19Cr	36Cr	13Cr
Earnings From Continuing Operations	45Cr	96Cr	20Cr	-50L	-8.5Cr
Earnings Of Discontinued Operations	-	-	-	-	2.5Cr
Net Income to Company	45Cr	96Cr	20Cr	-50L	-6Cr
Minority Interest	-90L	-1.4Cr	-30L	-	-20L
Net Income - (IS)	44Cr	95Cr	19Cr	-50L	-6.2Cr
Net Income to Common Incl Extra Items	44Cr	95Cr	19Cr	-50L	-6.2Cr
Net Income to Common Excl. Extra Items	44Cr	95Cr	19Cr	-50L	-8.7Cr
Per Share Items
Net EPS - Basic	-	-	1.82	-0.05	-0.6
Basic EPS - Continuing Operations	-	-	1.82	-0.05	-0.85
Basic Weighted Average Shares Outstanding	-	-	11Cr	10Cr	10Cr
Net EPS - Diluted	-	-	1.82	-0.05	-0.6
Diluted EPS - Continuing Operations	-	-	1.82	-0.05	-0.85
Diluted Weighted Average Shares Outstanding	-	-	11Cr	11Cr	10Cr
Normalized Basic EPS	-	-	3.77	3.75	2.25
Normalized Diluted EPS	-	-	3.75	3.72	2.24
Dividend Per Share	-	-	1.62	1.62	1.62
Payout Ratio	61.04	24.95	225.91	-3.66T	-303.23
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	120.7Cr	181Cr	159.9Cr	126.4Cr	120.3Cr
EBITA	90Cr	147Cr	124.6Cr	88Cr	62Cr
EBIT	74Cr	130.4Cr	108.4Cr	72Cr	50Cr
Effective Tax Rate - (Ratio)	4.63	0.21	49.48	101.42	302.38
Total Current Taxes	16Cr	26Cr	25Cr	15Cr	15Cr
Total Deferred Taxes	-14Cr	-25Cr	-6.2Cr	21Cr	-2Cr
Normalized Net Income	36Cr	66Cr	40Cr	39Cr	23Cr
Interest on Long-Term Debt	1.1Cr	1.1Cr	1.2Cr	1.3Cr	1.2Cr
Non-Cash Pension Expense	0	50L	1.6Cr	-1.5Cr	-50L
Supplemental Operating Expense Items
Selling and Marketing Expenses	20Cr	22Cr	30Cr	31Cr	30Cr
General and Administrative Expenses	51Cr	62Cr	52Cr	70Cr	59Cr
Research And Development Expense From Footnotes	29Cr	31Cr	34Cr	34Cr	30Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14Cr	24Cr	115Cr	66Cr	86Cr
Short Term Investments	6.8Cr	5.3Cr	7.3Cr	8.1Cr	9Cr
Trading Asset Securities, Total	-	-	-	-	10L
Total Cash And Short Term Investments	21Cr	30Cr	122.3Cr	74Cr	95Cr
Accounts Receivable, Total	87Cr	102.7Cr	91Cr	95Cr	79Cr
Other Receivables	155.3Cr	179.7Cr	32Cr	29Cr	24Cr
Notes Receivable	17Cr	15Cr	30L	40L	20L
Total Receivables	259.4Cr	297.1Cr	123.2Cr	124Cr	103.2Cr
Inventory	114.7Cr	139.2Cr	124.4Cr	127.3Cr	108.1Cr
Prepaid Expenses	2.5Cr	2.3Cr	4.3Cr	2.1Cr	3Cr
Other Current Assets, Total	3.9Cr	4Cr	4.4Cr	2Cr	20Cr
Total Current Assets	401.2Cr	472.3Cr	378.6Cr	329.4Cr	329.6Cr
Gross Property Plant And Equipment	733.2Cr	786.5Cr	857.9Cr	936.2Cr	865Cr
Accumulated Depreciation	-421.4Cr	-451.7Cr	-489.7Cr	-544.5Cr	-508.3Cr
Net Property Plant And Equipment	311.8Cr	334.8Cr	368.2Cr	391.7Cr	356.7Cr
Long-term Investments	36Cr	31Cr	35Cr	34Cr	27Cr
Goodwill	257.7Cr	267.1Cr	256Cr	265.9Cr	246.9Cr
Other Intangibles, Total	164Cr	157.4Cr	140.6Cr	134Cr	107.9Cr
Loans Receivable Long-Term	38Cr	14Cr	20Cr	14Cr	17Cr
Deferred Tax Assets Long-Term	37Cr	62Cr	66Cr	39Cr	36Cr
Deferred Charges Long-Term	23Cr	24Cr	25Cr	30Cr	30Cr
Other Long-Term Assets, Total	-10L	-10L	-	-10L	-10L
Total Assets	1.27TCr	1.36TCr	1.29TCr	1.24TCr	1.15TCr
Liabilities
Accounts Payable, Total	84Cr	97Cr	92Cr	100.1Cr	82Cr
Accrued Expenses, Total	35Cr	38Cr	53Cr	35Cr	31Cr
Current Portion of Long-Term Debt	364.7Cr	397.6Cr	10Cr	23Cr	4.1Cr
Current Portion of Leases	4.3Cr	4.9Cr	5.3Cr	6.2Cr	5.9Cr
Current Income Taxes Payable	7.7Cr	8.5Cr	5.8Cr	2.5Cr	7.8Cr
Other Current Liabilities	19Cr	27Cr	19Cr	26Cr	27Cr
Total Current Liabilities	514.9Cr	573.9Cr	184.4Cr	192.9Cr	157.4Cr
Long-Term Debt	191.6Cr	168.4Cr	199.3Cr	165.4Cr	271.5Cr
Long-Term Leases	17Cr	17Cr	17Cr	17Cr	15Cr
Pension & Other Post Retirement Benefits	43Cr	34Cr	37Cr	40Cr	32Cr
Deferred Tax Liability Non Current	44Cr	48Cr	43Cr	38Cr	33Cr
Other Non Current Liabilities	23Cr	28Cr	48Cr	36Cr	33Cr
Total Liabilities	834.2Cr	868.7Cr	528.5Cr	489Cr	541.2Cr
Common Stock, Total	446.9Cr	500.1Cr	135.2Cr	135.2Cr	135.2Cr
Additional Paid In Capital	-	-	610.1Cr	587.1Cr	102.2Cr
Retained Earnings	-	-	-	-	449.6Cr
Treasury Stock	-	-	-5.9Cr	-13Cr	-16Cr
Comprehensive Income and Other	-15Cr	-7.9Cr	17Cr	34Cr	-66Cr
Total Common Equity	431.5Cr	492.2Cr	756.7Cr	743.3Cr	605.4Cr
Minority Interest	1.8Cr	2.4Cr	4.2Cr	5Cr	3.8Cr
Total Equity	433.3Cr	494.6Cr	760.9Cr	748.3Cr	609.2Cr
Total Liabilities And Equity	1.27TCr	1.36TCr	1.29TCr	1.24TCr	1.15TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	11Cr	10Cr	10Cr
ECS Total Common Shares Outstanding	-	-	11Cr	10Cr	10Cr
Book Value / Share	-	-	67.22	67.07	59.38
Tangible Book Value	9.8Cr	68Cr	360.1Cr	343.4Cr	250.6Cr
Tangible Book Value Per Share	-	-	29.53	28.42	24.58
Total Debt	577.8Cr	587.6Cr	231.3Cr	211.5Cr	296.1Cr
Net Debt	557.1Cr	557.9Cr	109Cr	137.5Cr	200.9Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	17Cr	24Cr	19Cr	25Cr	16Cr
Minority Interest, Total (Incl. Fin. Div)	1.8Cr	2.4Cr	4.2Cr	5Cr	3.8Cr
Equity Method Investments, Total	21Cr	20Cr	21Cr	21Cr	19Cr
Account Code - Inventory Valuation	-	6	6	6	6
Inventories - Raw Materials, Total	39Cr	50Cr	44Cr	44Cr	38Cr
Inventories - Work In Process, Total	1.6Cr	1.5Cr	1.1Cr	1.3Cr	1.5Cr
Inventories - Finished Goods, Total	81Cr	95Cr	88Cr	90Cr	76Cr
Land - (BS)	138.4Cr	141.2Cr	152.8Cr	165Cr	153.6Cr
Machinery, Total	496.3Cr	522.4Cr	551.9Cr	607.6Cr	565.6Cr
Full Time Employees	-	12.87T	12.88T	12.69T	12.9T
Part Time Employees	-	-	217	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	90L	1.2Cr	1.5Cr	1.5Cr	1Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	44Cr	95Cr	19Cr	-50L	-6.2Cr
Depreciation & Amortization - CF	36Cr	39Cr	41Cr	46Cr	58Cr
Amortization of Goodwill and Intangible Assets - (CF)	16Cr	17Cr	16Cr	17Cr	12Cr
Depreciation & Amortization, Total	52Cr	56Cr	57Cr	62Cr	71Cr
Amortization of Deferred Charges, Total - (CF)	6.1Cr	5.8Cr	4.8Cr	4.7Cr	-
Asset Writedown & Restructuring Costs	50L	40L	12Cr	6.4Cr	-
(Income) Loss On Equity Investments - (CF)	-1.3Cr	-1.6Cr	-2.5Cr	-2.1Cr	-1.9Cr
Net Cash From Discontinued Operations	-	-	-	-	-1.3Cr
Other Operating Activities, Total	-8.9Cr	4.4Cr	26Cr	26Cr	16Cr
Change In Accounts Receivable	-20Cr	-14Cr	15Cr	-3.9Cr	5.4Cr
Change In Inventories	-29Cr	-22Cr	11Cr	20L	4.1Cr
Change In Accounts Payable	24Cr	8.2Cr	-8.1Cr	4.4Cr	-5.1Cr
Change in Other Net Operating Assets	-30L	1.5Cr	-7.4Cr	-13Cr	-3.3Cr
Cash from Operations	68Cr	133.6Cr	127.5Cr	84Cr	78Cr
Capital Expenditure	-34Cr	-52Cr	-76Cr	-51Cr	-43Cr
Sale of Property, Plant, and Equipment	1.5Cr	70L	10L	90L	40L
Cash Acquisitions	-2.2Cr	-	-20L	-40L	-
Divestitures	6.1Cr	6.6Cr	3.2Cr	1.3Cr	1.8Cr
Sale (Purchase) of Intangible assets	-5.7Cr	-6.9Cr	-8.8Cr	-12Cr	-10Cr
Investment in Marketable and Equity Securities, Total	-1.4Cr	-20L	-1.5Cr	-30L	-1.7Cr
Other Investing Activities, Total	-25Cr	-12Cr	-40Cr	-30L	10L
Cash from Investing	-62Cr	-64Cr	-123.1Cr	-61Cr	-53Cr
Long-Term Debt Issued, Total	20Cr	43Cr	175.5Cr	131.5Cr	166.8Cr
Total Debt Issued	20Cr	43Cr	175.5Cr	131.5Cr	166.8Cr
Long-Term Debt Repaid, Total	-38Cr	-46Cr	-326.1Cr	-162.7Cr	-74Cr
Total Debt Repaid	-38Cr	-46Cr	-326.1Cr	-162.7Cr	-74Cr
Issuance of Common Stock	-	-	30L	-	-
Repurchase of Common Stock	-	-	-	-14Cr	-62Cr
Common Dividends Paid	-27Cr	-24Cr	-44Cr	-18Cr	-19Cr
Common & Preferred Stock Dividends Paid	-27Cr	-24Cr	-44Cr	-18Cr	-19Cr
Other Financing Activities, Total	33Cr	-30Cr	282.9Cr	-9.1Cr	-9.1Cr
Cash from Financing	-13Cr	-58Cr	89Cr	-72Cr	2.8Cr
Foreign Exchange Rate Adjustments	50L	-1Cr	-2.8Cr	20L	-6.3Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-1.3Cr
Net Change in Cash	-6.4Cr	11Cr	91Cr	-49Cr	20Cr
Supplemental Items
Cash Income Tax Paid (Refund)	12Cr	18Cr	29Cr	18Cr	9Cr
Levered Free Cash Flow	12Cr	39Cr	216.15Cr	37Cr	45Cr
Unlevered Free Cash Flow	19Cr	48Cr	228.65Cr	45Cr	53Cr
Change In Net Working Capital	45Cr	37Cr	-183.9Cr	4.5Cr	-4.8Cr
Net Debt Issued / Repaid	-19Cr	-3.5Cr	-150.6Cr	-31Cr	92Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.83	6.2	5.11	3.54	2.6
Return on Total Capital	4.87	7.79	6.53	4.58	3.32
Return On Equity %	12.22	20.78	3.12	-0.07	-1.25
Return on Common Equity	12.03	20.57	3.09	-0.07	-1.29
Margin Analysis
Gross Profit Margin %	31.23	32.06	33.62	32.41	30.93
SG&A Margin	11.69	10.39	11.56	14.68	14.79
EBITDA Margin %	20.01	22.28	22.63	18.46	20.15
EBITA Margin %	14.95	18.1	17.64	12.87	10.37
EBIT Margin %	12.22	16.05	15.34	10.44	8.31
Income From Continuing Operations Margin %	7.51	11.87	2.77	-0.07	-1.42
Net Income Margin %	7.36	11.7	2.73	-0.07	-1.04
Net Avail. For Common Margin %	7.36	11.7	2.73	-0.07	-1.46
Normalized Net Income Margin	5.97	8.08	5.65	5.73	3.86
Levered Free Cash Flow Margin	1.99	4.84	30.59	5.42	7.53
Unlevered Free Cash Flow Margin	3.09	5.86	32.36	6.51	8.88
Asset Turnover
Asset Turnover	0.5	0.62	0.53	0.54	0.5
Fixed Assets Turnover	2	2.51	2.01	1.8	1.6
Receivables Turnover (Average Receivables)	7.93	8.56	7.31	7.38	6.88
Inventory Turnover (Average Inventory)	4.27	4.35	3.56	3.68	3.5
Short Term Liquidity
Current Ratio	0.78	0.82	2.05	1.71	2.09
Quick Ratio	0.51	0.54	1.33	1.02	1.26
Operating Cash Flow to Current Liabilities	0.13	0.23	0.69	0.44	0.49
Days Sales Outstanding (Average Receivables)	46.05	42.64	49.96	49.59	53.08
Days Outstanding Inventory (Average Inventory)	85.57	83.96	102.57	99.55	104.2
Average Days Payable Outstanding	57.02	57.53	75.94	75.42	84.36
Cash Conversion Cycle (Average Days)	74.6	69.07	76.59	73.71	72.92
Long Term Solvency
Total Debt/Equity	133.35	118.8	30.4	28.26	48.6
Total Debt / Total Capital	57.15	54.3	23.31	22.04	32.71
LT Debt/Equity	48.19	37.42	28.37	24.35	46.96
Long-Term Debt / Total Capital	20.65	17.1	21.76	18.98	31.6
Total Liabilities / Total Assets	65.81	63.72	40.99	39.52	47.04
EBIT / Interest Expense	6.89	9.88	5.42	5.96	3.84
EBITDA / Interest Expense	11.76	14.12	8.28	11.13	9.33
(EBITDA - Capex) / Interest Expense	8.53	10.17	4.47	6.89	5.99
Total Debt / EBITDA	4.59	3.15	1.4	1.58	2.46
Net Debt / EBITDA	4.43	2.99	0.66	1.03	1.67
Total Debt / (EBITDA - Capex)	6.33	4.38	2.59	2.56	3.83
Net Debt / (EBITDA - Capex)	6.1	4.16	1.22	1.66	2.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.1	34.67	-13.02	-3.1	-7.39
Gross Profit, 1 Yr. Growth %	20.77	38.22	-8.79	-6.57	-14.62
EBITDA, 1 Yr. Growth %	22.04	49.96	-11.85	-20.95	-11.87
EBITA, 1 Yr. Growth %	37.29	62.97	-15.24	-29.29	-25.6
EBIT, 1 Yr. Growth %	63.41	76.93	-16.87	-34.04	-28.94
Earnings From Cont. Operations, 1 Yr. Growth %	-135.34	112.8	-79.67	-102.55	-307.32
Net Income, 1 Yr. Growth %	-134.55	113.96	-79.68	-102.59	1.14T
Normalized Net Income, 1 Yr. Growth %	-155.83	82.03	-39.54	-1.6	-39.84
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-79.71	-102.75	-317.64
Accounts Receivable, 1 Yr. Growth %	33.79	17.91	-11.68	4.52	-16.88
Inventory, 1 Yr. Growth %	43.73	21.36	-10.63	2.33	-15.08
Net Property, Plant and Equip., 1 Yr. Growth %	6.74	7.38	9.98	6.38	-8.94
Total Assets, 1 Yr. Growth %	11.47	7.56	-5.42	-4.04	-7.02
Tangible Book Value, 1 Yr. Growth %	-109.23	590.82	431.91	-4.64	-27.02
Common Equity, 1 Yr. Growth %	40.78	14.07	53.74	-1.77	-18.55
Cash From Operations, 1 Yr. Growth %	-38.1	97.63	-4.57	-34.04	-7.37
Capital Expenditures, 1 Yr. Growth %	46.81	51.3	45.98	-33.2	-15.52
Levered Free Cash Flow, 1 Yr. Growth %	-	228.6	443.77	-82.84	24.87
Unlevered Free Cash Flow, 1 Yr. Growth %	-	155.06	376.35	-80.5	22.05
Dividend Per Share, 1 Yr. Growth %	-	-	-	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	22.86	8.22	-8.2	-8.08
Gross Profit, 2 Yr. CAGR %	-	29.2	12.28	-7.69	-11.84
EBITDA, 2 Yr. CAGR %	-	35.28	15.1	-16.53	-13.26
EBITA, 2 Yr. CAGR %	-	49.58	17.53	-22.58	-29.52
EBIT, 2 Yr. CAGR %	-	70.04	21.28	-25.95	-32.36
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-13.28	-34.22	-92.8	-34.15
Net Income, 2 Yr. CAGR %	-	-14.02	-34.07	-92.75	-43.32
Normalized Net Income, 2 Yr. CAGR %	-	0.81	5.21	-22.87	-23.98
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-92.53	-31.71
Accounts Receivable, 2 Yr. CAGR %	-	25.6	2.05	-3.92	-6.79
Inventory, 2 Yr. CAGR %	-	32.07	4.14	-4.37	-6.78
Net Property, Plant and Equip., 2 Yr. CAGR %	-	7.06	8.67	8.16	-1.57
Total Assets, 2 Yr. CAGR %	-	9.5	0.86	-4.73	-5.54
Tangible Book Value, 2 Yr. CAGR %	-	-20.16	506.18	125.22	-16.58
Common Equity, 2 Yr. CAGR %	-	26.72	32.43	22.89	-10.55
Cash From Operations, 2 Yr. CAGR %	-	10.61	37.34	-20.66	-21.83
Capital Expenditures, 2 Yr. CAGR %	-	49.04	48.62	-1.25	-24.88
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	324.85	-3.41	-54.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	250.03	-3.62	-51.85
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	9.5	4.31	-9.76
Gross Profit, 3 Yr. CAGR %	-	-	15.04	5.61	-10.83
EBITDA, 3 Yr. CAGR %	-	-	17.37	1.55	-12.79
EBITA, 3 Yr. CAGR %	-	-	23.78	-0.78	-25.05
EBIT, 3 Yr. CAGR %	-	-	33.95	-1.01	-27.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-46.53	-77.74	-55.49
Net Income, 3 Yr. CAGR %	-	-	-46.84	-77.59	-59.74
Normalized Net Income, 3 Yr. CAGR %	-	-	-14.82	2.89	-29.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-54.43
Accounts Receivable, 3 Yr. CAGR %	-	-	11.69	2.86	-8.45
Inventory, 3 Yr. CAGR %	-	-	15.95	3.54	-8.08
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	8.02	7.9	2.13
Total Assets, 3 Yr. CAGR %	-	-	4.28	-0.8	-5.5
Tangible Book Value, 3 Yr. CAGR %	-	-	50.23	227.23	54.69
Common Equity, 3 Yr. CAGR %	-	-	35.15	19.87	7.14
Cash From Operations, 3 Yr. CAGR %	-	-	5.3	7.55	-16.46
Capital Expenditures, 3 Yr. CAGR %	-	-	48.01	13.84	-6.26
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	45.76	4.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	33.68	3.36
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	2.1
Gross Profit, 5 Yr. CAGR %	-	-	-	-	3.42
EBITDA, 5 Yr. CAGR %	-	-	-	-	4
EBITA, 5 Yr. CAGR %	-	-	-	-	-1.18
EBIT, 5 Yr. CAGR %	-	-	-	-	1.92
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-41.88
Net Income, 5 Yr. CAGR %	-	-	-	-	-45.46
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-18.61
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	3.89
Inventory, 5 Yr. CAGR %	-	-	-	-	6.26
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	4.08
Total Assets, 5 Yr. CAGR %	-	-	-	-	0.23
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	18.73
Common Equity, 5 Yr. CAGR %	-	-	-	-	14.58
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-6.53
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	12.84